Natus Sensory Expands Canadian Footprint via CHS Partnership

Event summary

  • Natus Sensory and Canadian Hospital Specialties (CHS) signed a multi-year distribution and collaboration agreement effective February 2026.
  • CHS will represent Natus Sensory’s full newborn care portfolio, including hearing screening, vision screening, phototherapy, and NICU connectivity solutions.
  • The partnership includes joint clinical education and implementation support programs.
  • Natus Sensory is an ARCHIMED company, expanding its reach in the Canadian healthcare market.

The big picture

This partnership aligns with the broader trend of medical device companies leveraging local distributors to enhance market penetration and clinical adoption. Natus Sensory’s collaboration with CHS underscores the strategic importance of Canada as a growth market, particularly in neonatal care where integrated solutions and education are critical. The deal reflects a shift toward long-term, value-driven partnerships in healthcare, emphasizing not just distribution but sustained customer success.

What we're watching

Market Penetration
How the partnership will accelerate adoption of Natus Sensory’s solutions across Canadian hospitals.
Clinical Impact
Whether the joint education and implementation programs will drive sustained utilization of newborn care technologies.
Competitive Dynamics
The pace at which Natus Sensory can differentiate itself in the Canadian neonatal care market.